Biology of mitochondria in neurodegenerative diseases

Progress in Molecular Biology and Translational Science

Volumn 107, Issue , 2012, Pages 355-415

  Martin, Lee J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenine nucleotide translocator; Apoptosis; Cell death; Cyclophilin D; Excitotoxicity; Keywords; Mitochondrial permeability transition pore; Motor neuron; ppif; Voltage dependent anion channel

Indexed keywords

EID: 84859598872     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385883-2.00005-9     Document Type: Chapter

References (374)

1. D.B. Zorov, N.K. Isave, E.Y. Plotnikov, L.D. Zorova, E.V. Stelmashook, and A.K. Vasileva The mitochondrion as Janus Bifrons Biochemistry (Mosc) 72 2007 1115 1126 (Pubitemid 350022593)
2. B. Halliwell Role of free radicals in the neurodegenerative diseases Drugs Aging 18 2001 685 716
3. D.G. Nicholls Mitochondrial function and dysfunction in the cell: its relevance to aging and aging-related disease Int J Biochem Cell Biol 34 2002 1372 1381 (Pubitemid 35245396)
4. D.C. Wallace A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn of evolutionary medicine Annu Rev Genet 39 2002 359 407 (Pubitemid 43011120)
5. I. Fridovich Superoxide radical and superoxide dismutases Annu Rev Biochem 64 1995 97 112
6. I.N. Mungrue, D.S. Bredt, D.J. Stewart, and M. Husain From molecules to mammals: what's NOS got to do with it? Acta Physiol Scand 179 2003 123 135 (Pubitemid 37249246)
7. L.J. Martin Mitochondrial and cell death mechanisms in neurodegenerative disease Pharmaceuticals 3 2010 839 915
8. C. Delettre, G. Lenaers, L. Pelloquin, P. Belenguer, and C.P. Hamel OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease Mol Genet Metab 75 2002 97 107 (Pubitemid 34975762)
9. H. Chen, and D.C. Chan Emerging functions of mammalian mitochondrial fusion and fission Hum Mol Genet 14 2005 R283 R289
10. M.D. Brown, A.S. Voljavec, M.T. Lott, I. MacDolald, and D.C. Wallace Leber's hereditary optic neuropathy: a model for mitochondrial neurodegenerative diseases FASEB J 6 1992 2791 2799
11. L.-J.C. Wong, R.K. Naviaux, N. Brunetti-Pierri, Q. Zhang, E.S. Schmitt, and C. Truong Molecular and clinical genetics of mitochondrial disease due to POLG mutations Hum Mutat 29 2008 E150 E172
12. S. Goffart, H.M. Cooper, H. Tyynismaa, S. Wanrooij, A. Suomalainen, and J.N. Spelbrink Twinkle mutations associated with autosomal dominant progressive external opthalmoplegia lead to impaired helicase function and in vivo mtDNA replication stalling Hum Mol Genet 18 2009 328 340
13. H. Komaki, T. Fukazawa, H. Houzen, K. Yoshida, I. Nonaka, and Y. Goto A novel D104G mutation in the adenine nucleotide translocator 1 gene in autosomal dominant external opthalmoplegia patients with mitochondrial DNA with multiple deletions Ann Neurol 51 2002 645 648
14. L.J. Martin, N.A. Al-Abdulla, A.M. Brambrink, J.R. Kirsch, F.E. Sieber, and C. Portera-Cailliau Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis Brain Res Bull 46 1998 281 309 (Pubitemid 28294822)
15. F.J. Northington, E.M. Graham, and L.J. Martin Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited? Brain Res Rev 50 2005 244 257 (Pubitemid 41654395)
16. L.J. Martin The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis Biochim Biophys Acta 1802 2010 186 197
17. P.C. Waldmeier, K. Zimmermann, T. Qian, M. Tintelnot-Blomley, and J.J. Lemasters Cyclophilin D as a drug target Curr Med Chem 10 2003 1485 1506 (Pubitemid 36896552)
18. M. Crompton Mitochondria and aging: a role for the permeability transition? Aging Cell 3 2004 3 6 (Pubitemid 40246654)
19. A.P. Halestrap What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 46 2009 821 831
20. P. Bernardi, A. Krauskopf, E. Basso, V. Petronilli, E. Blalchy-Dyson, and F. Di Lisa The mitochondrial permeability transition from in vitro artifact to disease target FEBS J 273 2006 2077 2099
21. C. Caspersen, N. Wang, J. Yao, A. Sosunov, X. Chen, and J.W. Lustbader Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease FASEB J 19 2005 2040 2041 (Pubitemid 41759758)
22. J.S. Beckman, M. Carson, C.D. Smith, and W.H. Koppenol ALS, SOD and peroxynitrite Nature 364 1993 548
23. L.J. Martin, and Z. Liu DNA damage profiling in motor neurons: a single-cell analysis by comet assay Neurochem Res 27 2002 1089 1100
24. C. Giulini Characterization and function of mitochondrial nitric-oxide synthase Free Radic Biol Med 34 2003 397 408
25. G.C. Brown, and V. Borutaite Nitric oxide, cytochrome c, and mitochondria Biochem Soc Symp 66 1999 17 25
26. D.W. Choi Cellular defences destroyed Nature 433 2005 696 698
27. 2 + overload than nonsynaptic mitochondria J Biol Chem 281 2006 11658 11668 (Pubitemid 43855423)
28. N.W. Soong, D.R. Hinton, G. Cortopassi, and N. Arnheim Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain Nat Genet 2 1992 318 323
29. M. Corral-Debrinski, T. Horton, M.T. Lott, J.M. Shoffner, M.F. Beal, and D.C. Wallace Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age Nat Genet 2 1992 324 329
30. W.J. Driggers, S.P. LeDoux, and G.L. Wilson Repair of oxidative damage within the mitochondrial DNA or RINr 38 cells J Biol Chem 268 1993 22042 22045 (Pubitemid 23320713)
31. N.B. Larsen, M. Rasmussen, and L.J. Rasmussen Nuclear and mitochondrial DNA repair: similar pathways? Mitochondrion 5 2005 89 108 (Pubitemid 40485769)
32. B. Szczesny, T.K. Hazra, J. Papaconstantinou, S. Mitra, and I. Boldogh Age-dependent deficiency in import of mitochondrial DNA glycosylases required for repair of oxidatively damaged bases Proc Natl Acad Sci USA 100 2003 10670 10675 (Pubitemid 37140086)
33. P.A. Popp, and W.C. Copeland Cloning and characterization of the human mitochondrial DNA polymerase, DNA polymerase gamma Genomics 36 1996 449 458 (Pubitemid 26321967)
34. S. Gunawardena, and L.S.B. Goldstein Cargo-carrying motor vehicles on the neuronal highway: transport pathways and neurodegenerative disease J Neurobiol 58 2003 258 271 (Pubitemid 38173723)
35. S.R. Chada, and P.J. Hollenbeck Mitochondrial movement and positioning in axons: the role of growth factor signaling J Exp Biol 206 2003 1985 1992 (Pubitemid 36761801)
36. Y. Tanaka, Y. Kanai, Y. Okada, S. Nonaka, S. Takeda, and A. Harada Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria Cell 93 1998 1147 1158 (Pubitemid 28307420)
37. L.A. Ligon, and O. Steward Role of microtubules and actin filaments in the movement of mitochondria in the axons and dendrites of cultured hippocampal neurons J Comp Neurol 427 2000 351 361
38. G.L. Pintoul, A.J. Filiano, J.B. Brocard, G.J. Kress, and I.J. Reynolds Glutamate decreases mitochondrial size and movement in primary forebrain neurons J Neurosci 23 2003 7881 7888 (Pubitemid 37052356)
39. I.J. Reynolds, L.M. Malaiyandi, M. Coash, and G.L. Rintoul Mitochondrial trafficking in neurons: a key variable in neurodegeneration? J Bioeng Biomembr 36 2004 283 286 (Pubitemid 39619827)
40. K.E. Miller, and M.P. Sheetz Axonal mitochondrial transport and potential are correlated J Cell Sci 117 2004 2791 2804 (Pubitemid 38997261)
41. Y. Tatebayashi, N. Haque, Y.C. Tung, K. Iqbal, and I. Grundke-Iqbal Role of tau phosphorylation by glycogen synthase kinase-3β in the regulation of organelle transport J Cell Sci 117 2004 1653 1663 (Pubitemid 38559298)
42. L.J. Martin Neuronal cell death in nervous system development, disease, and injury Int J Mol Med 7 2001 455 478
43. R.A. Lockshin, and Z. Zakeri Caspase-independent cell deaths Curr Opin Cell Biol 14 2002 727 733 (Pubitemid 35449385)
44. S. Gilbert Developmental biology 2006 Sinauer Associates Sunderland
45. J.C. Ameisen On the origin, evolution, and nature of programmed cell death: a timeline of four billion years Cell Death Differ 9 2002 367 393 (Pubitemid 34822817)
46. M.M. Metzstein, G.M. Stanfield, and H.R. Horvitz Genetics of programmed cell death in C. elegans: past, present and future Trends Genet 14 1998 410 416 (Pubitemid 28505585)
47. R.J. Youle, and A. Strasser The Bcl-2 protein family: opposing activities that mediate cell death Nat Rev 9 2008 47 59
48. D.E. Merry, and S.J. Korsmeyer Bcl-2 gene family in the nervous system Annu Rev Neurosci 20 1997 245 267
49. S. Cory, and J.M. Adams The bcl-2 family: regulators of the cellular life-or-death switch Nat Rev 2 2002 647 656 (Pubitemid 37328916)
50. B.B. Wolf, and D.R. Green Suicidal tendencies: apoptotic cell death by caspase family proteinases J Biol Chem 274 1999 20049 20052
51. S. Nagata Fas ligand-induced apoptosis Annu Rev Genet 33 1999 29 55 (Pubitemid 30083118)
52. M. Levrero, V. De Laurenzi, A. Costanzo, S. Sabatini, J. Gong, and J.Y.J. Wang The p53/p63/p73 family of transcription factors: overlapping and distinct functions J Cell Sci 113 2000 1661 1670 (Pubitemid 30333115)
53. P. Li, D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, and E.S. Alnemri Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade Cell 91 1997 479 489 (Pubitemid 27508237)
54. X. Liu, C.N. Kim, J. Yang, R. Jemmerson, and X. Wang Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c Cell 86 1996 147 157 (Pubitemid 26256586)
55. J.A. Klein, C.M. Longo-Guess, M.P. Rossmann, R.E. Seburn, R.E. Hurd, and W.N. Frankel The harlequin mouse mutation downregulates apoptosis-inducing factor Nature 419 2002 367 374
56. R. Hegde, S.M. Srinivasula, Z. Zhang, R. Wassell, R. Mukattash, and L. Cilentei Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction J Biol Chem 277 2002 432 4538
57. P. Liston, N. Roy, K. Tamai, C. Lefebvre, S. Baird, and G. Cherton-Horvat Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes Nature 379 1996 349 353 (Pubitemid 26033078)
58. 2 + : a control point for apoptosis Science 300 2003 135 139 (Pubitemid 36423046)
59. S.W. Muchmore, M. Sattler, H. Liang, R.P. Meadows, J.E. Harlan, and H.S. Yoon X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death Nature 381 1999 335 341
60. B. Antonsson, F. Conti, A. Ciavatta, S. Montessuit, S. Lewis, and I. Martinou Inhibition of bax channel-forming activity by bcl-2 Science 277 1997 370 372 (Pubitemid 27450709)
61. A. Letai, M.C. Bassik, L.D. Walensky, M.D. Sorcinelli, S. Weiler, and S.J. Korsmeyer Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics Cancer Cell 2 2002 183 192 (Pubitemid 41043974)
62. M.C. Wei, W.-X. Zong, E.H.-Y. Cheng, T. Lindsten, V. Panoutsakopoulou, and A.J. Ross Proapoptotic Bax and Bak: a requisite gateway to mitochondrial dysfunction and death Science 292 2001 727 730 (Pubitemid 32385543)
63. S. Shimizu, T. Ide, T. Yanagida, and Y. Tsujimoto Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c J Biol Chem 275 2000 12321 12325 (Pubitemid 30237814)
64. I. Chowdhury, B. Tharakan, and G.H. Bhat Caspases - an update Comp Biochem Physiol 51 2008 10 27
65. M. Mancini, D.W. Nicholson, S. Roy, N.A. Thornberry, E.P. Peterson, and L.A. Casciola-Rosen The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling J Cell Biol 140 1998 1485 1495 (Pubitemid 28152996)
66. S. Krajewski, M. Krajewska, L.M. Ellerby, K. Welsh, Z. Xie, and Q.L. Deveraus Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia Proc Natl Acad Sci USA 96 1999 5752 5757 (Pubitemid 29234690)
67. X. Liu, H. Zou, C. Slaughter, and X. Wang DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis Cell 89 1997 175 184 (Pubitemid 27199890)
68. H. Li, H. Zhu, C.-J. Xu, and J. Yuan Cleavage of Bid by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis Cell 94 1998 491 501 (Pubitemid 28391865)
69. J.D. Robertson, M. Enoksson, M. Suomela, B. Zhivotovsky, and S. Orrenius Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis J Biol Chem 277 2002 29803 29809
70. E.C. LaCasse, S. Baird, R.G. Korneluk, and A.E. MacKenzie The inhibitors of apoptosis (IAPs) and their emerging role in cancer Oncogene 17 1998 3247 3259 (Pubitemid 29043977)
71. M. Holcik The IAP proteins Trends Genet 18 2002 537 538 (Pubitemid 35287029)
72. Q.L. Deveraux, N. Roy, H.R. Stennicke, T. Van Arsdale, Q. Zhou, and S.M. Srinivasula IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases EMBO J 17 1998 2215 2223 (Pubitemid 28171907)
73. Y. Hao, K. Sekine, A. Kawabata, H. Nakamura, T. Ishioka, and H. Ohata Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function Nat Cell Biol 6 2004 849 860 (Pubitemid 39207250)
74. C. Du, M. Fang, Y. Li, L. Li, and X. Wang Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 102 2000 33 42
75. A.M. Verhagen, P.G. Ekert, M. Pakusch, J. Silke, L.M. Connolly, and G.E. Reid Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins Cell 102 2000 43 53
76. Y. Suzuki, Y. Imai, H. Nakayama, K. Takahashi, K. Takio, and R. Takahashi A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death Mol Cell 8 2001 613 621 (Pubitemid 32946938)
77. V. Bogaerts, K. Nuytemans, J. Reumers, R. Pals, S. Engelborghs, and B. Pickut Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson's disease Hum Mutat 29 2008 832 840 (Pubitemid 351794134)
78. S.A. Susin, H.K. Lorenzo, N. Zamzami, I. Marzo, B.E. Snow, and G.M. Brothers Molecular characterization of mitochondrial apoptosis-inducing factor Nature 397 1999 441 446
79. M.J. Mate, M. Ortiz-Lombardia, B. Boitel, A. Haouz, D. Tello, and S.A. Susin The crystal structure of the mouse apoptosis-inducing factor AIF Nat Struct Biol 9 2002 442 446 (Pubitemid 34568789)
80. i regulation in apoptosis, oncosis, and necrosis Biochim Biophys Acta 1313 1996 173 178 (Pubitemid 26342945)
81. G. Majno, and I. Joris Apoptosis, oncosis, and necrosis. An overview of cell death Am J Pathol 146 1995 3 15
82. B.J. Trump, P.J. Goldblatt, and R.E. Stowell Studies on necrosis of mouse liver in vitro. Ultrastructural alterations in the mitochondria of hepatic parenchymal cells Lab Invest 14 1964 343 371
83. E. Bonfoco, D. Krainc, M. Ankarcrona, P. Nicotera, and S.A. Lipton Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell culture Proc Natl Acad Sci USA 92 1995 7162 7166
84. M. Leist, B. Single, A.F. Castoldi, S. Kuhnles, and P. Nicotera Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis J Exp Med 185 1997 1481 1486 (Pubitemid 27187604)
85. W.C. Golden, A.M. Brambrink, R.J. Traystman, and L.J. Martin Failure to sustain recovery of Na, K ATPase function is a possible mechanism for striatal neurodegeneration in hypoxic-ischemic newborn piglets Mol Brain Res 88 2001 94 102 (Pubitemid 32274263)
86. 2 + overload Cell Death Differ 13 2006 1675 1685 (Pubitemid 44390855)
87. S.Y. Proskuryakov, A.G. Konoplyannikov, and V.L. Gabai Necrosis: a specific form of programmed cell death Exp Cell Res 283 2003 1 16 (Pubitemid 36259891)
88. Y.-S. Kim, M.J. Morgan, S. Choksi, and Z.-G. Lu TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death Mol Cell 26 2007 675 687 (Pubitemid 46856240)
89. J. Hitomi, D.E. Christofferson, A. Ng, J. Yao, A. Degterev, and R.J. Xavier Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway Cell 135 2008 1311 1323
90. C.P. Baines, R.A. Kaiser, N.H. Purcell, H.S. Blair, H. Osinska, and M.A. Hambleton Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death Nature 434 2005 658 662 (Pubitemid 40488559)
91. H.C. Ha, and S.H. Snyder Poly(ADP-ribose) polymerase-1 in the nervous system Neurobiol Dis 7 2000 225 239
92. M. Zoratti, and I. Szabo The mitochondrial permeability transition Biochem Biophys Acta 1241 1995 139 176
93. M. Crompton The mitochondrial permeability transition pore and its role in cell death Biochem J 341 1999 233 249 (Pubitemid 29373645)
94. M. van Gurp, N. Festjens, G. van Loo, X. Saelens, and P. Vandenabeele Mitochondrial intermembrane proteins in cell death Biochem Biophys Res Commun 304 2003 487 497 (Pubitemid 36506521)
95. A.W.C. Leung, and A.P. Halestrap Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore Biochim Biophys Acta 1777 2008 946 952
96. V. Shoshan-Barmatz, A. Israelson, D. Brdiczka, and S.S. Sheu The voltage-dependent anion channel (VDAC): function in intracellular signaling, cell life and cell death Curr Pharm Des 12 2006 2249 2270 (Pubitemid 43891398)
97. T.K. Rostovtseva, W. Tan, and M. Colombini On the role of VDAC in apoptosis: fact and fiction J Bioenerg Biomembr 37 2005 129 142 (Pubitemid 41420468)
98. W. Tan, and M. Colombini VDAC closure increases calcium ion flux Biochim Biophys Acta 1768 2007 2510 2515 (Pubitemid 47532032)
99. 2 + -induced mitochondrial permeability transition in rat liver mitochondria Arch Biochem Biophys 495 2010 174 181
100. D.J. Granville, and R.A. Gottlieb The mitochondrial voltage-dependent anion channel (VDAC) as a therapeutic target for initiating cell death Curr Med Chem 10 2003 1527 1533 (Pubitemid 36896554)
101. M. Huizing, W. Ruitenbeek, L.P. van den Heuvel, V. Dolce, V. Iacobazzi, and J.A.M. Smeitink Human mitochondrial transmembrane metabolite carriers: tissue distribution and its implication for mitochondrial disorders J Bioenerg Biomembr 30 1998 277 284 (Pubitemid 28405169)
102. S. Wu, M.J. Sampson, W.K. Decker, and W.J. Craigen Each mammalian mitochondrial outer membrane porin protein is dispensable: effects on cellular respiration Biochem Biophys Acta 1452 1999 68 78 (Pubitemid 29486743)
103. K. Anflous, D.D. Armstrong, and W.J. Craigen Altered sensitivity for ADP and maintenance of creatine-stimulated respiration in oxidative striated muscles from VDAC1-deficient mice J Biol Chem 276 2001 1954 1960 (Pubitemid 32109673)
104. M.J. Sampson, W.K. Decker, A.L. Beaudet, W. Ruitenbeek, D. Armstrong, and M.J. Hicks Immotile sperm and infertility in mice lacking mitochondrial voltage-dependent anion channel type 3 J Biol Chem 276 2001 39206 39212
105. E.H. Cheng, T.V. Sheiko, J.K. Fisher, W.J. Craigen, and S.J. Korsemeyer VDAC2 inhibits Bak activation and mitochondrial apoptosis Science 301 2003 513 517 (Pubitemid 36900308)
106. D. Chandra, G. Choy, P.T. Daniel, and D.G. Tang Bax-dependent regulation of Bak by voltage-dependent anion channel 2 J Biol Chem 280 2005 19051 19061 (Pubitemid 41379611)
107. C.P. Baines, R.A. Kaiser, T. Sheiko, W.J. Craigen, and J.D. Molkentin Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death Nat Cell Biol 9 2007 550 555 (Pubitemid 46696536)
108. A. Karachitos, H. Galganska, M. Wojtkowska, M. Budzinska, O. Stobienia, and G. Bartosz Cu, Zn-superoxide dismutase is necessary for proper function of VDAC in Saccharomyces cerevisiae cells FEBS Lett 583 2009 449 455
109. A.P. Halestrap, and C. Brenner The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death Curr Med Chem 10 2003 1507 1525 (Pubitemid 36896553)
110. B.H. Graham, K.G. Waymire, B. Cottrell, I.A. Trounce, G.R. MacGregor, and D.C. Wallace A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator Nat Genet 16 1997 226 234 (Pubitemid 27280204)
111. G. Stepien, A. Torroni, A.B. Chung, J.A. Hodge, and D.C. Wallace Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation J Biol Chem 267 1992 14592 14597
112. M.Y. Vyssokikh, A. Katz, A. Rueck, C. Wuensch, A. Dorner, and D.B. Zorov Adenine nucleotide translocator isoforms 1 and 2 are differently distributed in the mitochondrial inner membrane and have distinct affinities to cyclophilin D Biochem J 358 2001 349 358 (Pubitemid 32826351)
113. J.E. Kikoszka, K.G. Waymire, S.E. Levy, J.E. Sligh, J. Cai, and D.P. Jones The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore Nature 427 2004 461 465 (Pubitemid 38168501)
114. K. Machida, Y. Hayashi, and H. Osada A novel adenine nucleotide translocase inhibitor, MT-21, induces cytochrome c release through a mitochondrial permeability transition-independent mechanisms J Biol Chem 277 2002 31243 31248 (Pubitemid 34970832)
115. K. Woodfield, A. Rück, D. Brdiczka, and A.P. Halestrap Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition Biochem J 336 1998 287 290 (Pubitemid 28564382)
116. N. Johnson, A. Khan, S. Virji, J.M. Ward, and M. Crompton Import and processing of heart mitochondrial cyclophilin D Eur J Biochem 263 1999 353 359 (Pubitemid 29337025)
117. M.W. McEnery, T.M. Dawson, A. Verma, D. Gurley, M. Colombini, and S.H. Snyder Mitochondrial voltage-dependent anion channel J Biol Chem 268 1993 23289 23296
118. V. Shoshan-Barmatz, R. Zalk, D. Gincel, and N. Vardi Subcellular localization of VDAC in mitochondria and ER in the cerebellum Biochem Biophys Acta 1657 2004 105 114 (Pubitemid 38952871)
119. N. Akanda, R. Tofight, J. Brask, C. Tamm, F. Elinder, and S. Ceccatelli Voltage-dependent anion channels (VDAC) in the plasma membrane play a critical role in apoptosis in differentiated hippocampal neurons but not in neural stem cells Cell Cycle 7 2008 3225 3234
120. W.H. Yu, W. Wolfgang, and M. Forte Subcellular localization of human voltage-dependent anion channel isoforms J Biol Chem 270 1995 13998 14006
121. C.R. Buck, M.J. Jurynec, D.E. Upta, A.K.T. Law, J. Bilger, and D.C. Wallace Increased adenine nucleotide translocator 1 in reactive astrocytes facilitates glutamate transport Exp Neurol 181 2003 149 158 (Pubitemid 36629236)
122. J.L. Hazelton, M. Petrasheuskaya, G. Fiskum, and T. Kristian Cyclophilin D is expressed predominantly in mitochondria of γ-aminobutyric acidergic interneurons J Neurosci Res 87 2009 1250 1259
123. K.K. Naga, P.G. Sullivan, and J.W. Geddes High cyclophilin D content of synaptic mitochondria results in increased vulnerability to permeability transition J Neurosci 27 2007 7469 7475 (Pubitemid 47066566)
124. L.J. Martin, B. Gertz, Y. Pan, A.C. Price, J.D. Molkentin, and Q. Chang The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice Exp Neurol 218 2009 333 346
125. S. Bose, and R.B. Freedman Peptidyl prolyl cis-trans-isomerase activity associated with the lumen of the endoplasmic reticulum Biochem J 300 1994 865 870 (Pubitemid 24180605)
126. P.G. Sullivan, A.G. Rabchevsky, J.N. Keller, M. Lovell, A. Sodhi, and R.P. Hart Intrinsic differences in brain and spinal cord mitochondria: implications for therapeutic interventions J Comp Neurol 474 2004 524 534 (Pubitemid 38720422)
127. S. Morota, M.J. Hansson, N. Ishii, Y. Kudo, E. Elmer, and H. Uchino Spinal cord mitochondria display lower calcium retention capacity compared with brain mitochondria without inherent differences in sensitivity to cyclophilin D inhibition J Neurochem 103 2007 2066 2076 (Pubitemid 350126633)
128. T.J. Collins, and M.D. Bootman Mitochondria are morphologically heterogeneous within cells J Exp Biol 206 2003 1993 2000 (Pubitemid 36761802)
129. R.E. Jensen Control of mitochondrial shape Curr Opin Cell Biol 17 2005 384 388 (Pubitemid 40968068)
130. A. Hamberger, C. Blomstrand, and A.L. Lehninger Comparative studies of mitochondria isolated from neuron-enriched and glia-enriched fractions of rabbit and beef brain J Cell Biol 45 1970 221 234
131. D.J. Klionsky, and S.D. Emr Autophagy as a regulated pathway of cellular degradation Science 290 2000 1717 1721 (Pubitemid 32004796)
132. A.M. Tolkovsky, L. Xue, G.C. Fletcher, and V. Borutaite Mitochondrial disappearance from cells: a clue to the role of autophagy in programmed cell death and disease Biochimie 84 2002 233 240
133. D. Gozuacik, and A. Kimchi Autophagy as a cell death and tumor suppressor mechanism Oncogene 23 2004 2891 2906 (Pubitemid 38638851)
134. S.D. Ginsberg, and L.J. Martin Ultrastructural analysis of the progression of neurodegeneration in the septum following fimbria-fornix transaction Neuroscience 86 1998 1259 1272 (Pubitemid 28318550)
135. S.D. Ginsberg, C. Portera-Cailliau, and L.J. Martin Fimbria-fronix transection and excitotoxicity produce similar neurodegeneration in the septum Neuroscience 88 1999 1059 1071 (Pubitemid 28546989)
136. L.J. Martin, A. Kaiser, and A.C. Price Motor neuron degeneration after sciatic nerve avulsion in adult rat evolves with oxidative stress and is apoptosis J Neurobiol 40 1999 185 201 (Pubitemid 29343303)
137. N.A. Al-Abdulla, and L.J. Martin Apoptosis of retrogradely degenerating neurons occurs in association with accumulation of perikaryal mitochondria and oxidative damage to the nucleus Am J Pathol 153 1998 447 456 (Pubitemid 28373656)
138. L.J. Martin An approach to experimental synaptic pathology using green fluorescent protein-transgenic mice and gene knockout mice: excitotoxic vulnerability of interneurons and motoneurons is associated with mitochondrial accumulation and mediated by the mitochondrial permeability transition pore Toxicol Pathol 39 1 2011 220 233
139. P.G.H. Clarke Developmental cell death: morphological diversity and multiple mechanisms Anat Embryol 181 1990 195 213 (Pubitemid 20153523)
140. J.U. Schweichel, and H.J. Merker The morphology of various types of cell death in prenatal tissues Teratology 7 1973 253 266
141. L.Z. Xue, G.C. Fletcher, and A.M. Tolkovsky Autophagy is activated by apoptotic signaling in sympathetic neurons: an alternative mechanism of death execution Mol Cell Neurosci 14 1999 180 198 (Pubitemid 29449222)
142. Z. Yue, A. Horton, M. Bravin, P.L. DeJager, F. Selimi, and N. Heintz A novel protein complex linking the δ2 glutamate receptor and autophagy: implications for neurodegeneration in Lurcher mice Neuron 35 2002 921 933
143. T. Hara, K. Nakamura, M. Matsui, A. Yamamoto, Y. Nakahara, and R. Suzuki-Migishima Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice Nature 44 2006 885 889
144. M. Komatsu, S. Waguri, T. Chiba, S. Murata, J. Iwata, and I. Tanida Loss of autophagy in the central nervous system causes neurodegeneration in mice Nature 44 2006 880 884
145. D. Nakendra, A. Tanaka, D.-F. Suen, and R.J. Youle Parkin is recruited selectively to impaired mitochondria and promotes their autophagy J Cell Biol 183 2008 795 803
146. J. Yuan, M. Lipinski, and A. Degterev Diversity in the mechanisms of neuronal cell death Neuron 40 2003 401 413 (Pubitemid 37244104)
147. V. Todde, M. Veenhuis, and I.J. van der Klei Autophagy: principles and significance in health and disease Biochim Biophys Acta 1792 2009 3 13
148. W. Bursch The autophagosomal-lysosomal compartment in programmed cell death Cell Death Differ 8 2001 569 581 (Pubitemid 32590778)
149. B. Inbal, S. Bialik, I. Sabanay, G. Shani, and A. Kimchi DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death J Cell Biol 157 2002 455 468 (Pubitemid 34839809)
150. X.H. Liange, L.K. Kleeman, H.H. Jiang, G. Gordon, J.E. Goldman, and G. Berry Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein J Virol 72 1998 8586 8596 (Pubitemid 28471796)
151. E. Ogier-Denis, and P. Codogno Autophagy: a barrier or an adaptive response to cancer Biochim Biophys Acta 1603 2003 113 128 (Pubitemid 36266686)
152. A. Varadi, L.I. Johnson-Cadwell, V. Cirulli, Y. Yoon, V.J. Allan, and G.A. Rutter Cytoplasmic dynein regulates the subcellular distribution of mitochondria by controlling the recruitment of the fission factor dynamin-related protein-1 J Cell Sci 117 2004 4389 4400 (Pubitemid 39360066)
153. M. Karbowski, Y.-L. Lee, B. Gaume, S.-Y. Jeong, S. Frank, and A. Nechushtan Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis J Cell Biol 159 2002 931 938 (Pubitemid 36055748)
154. A.F. Davis, and D.A. Clayton In situ localization of mitochondrial DNA replication in intact mammalian cells J Cell Biol 135 1996 883 893 (Pubitemid 26403766)
155. E. Nisoli, E. Clementi, C. Paolucci, V. Cozzi, C. Tonello, and C. Sciorati Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide Science 299 2003 896 899 (Pubitemid 36182449)
156. R. Katzman Education and the prevalence of dementia and Alzheimer's disease Neurology 43 1993 13 20 (Pubitemid 23035350)
157. D.A. Evans, H.H. Funkenstein, M.S. Albert, P.A. Scherr, N.R. Cook, and M.J. Chown Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported JAMA 262 1989 2551 2556
158. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force on Alzheimer's disease Neurology 34 1984 939 944 (Pubitemid 14076461)
159. S.J. Olshansky, B.A. Carnes, and C.K. Cassel The aging of the human species Sci Am 268 1993 46 52 (Pubitemid 23218773)
160. L. Minati, T. Edginton, M.G. Bruzzone, and G. Giaccone Current concepts in Alzheimer's disease: a multidisciplinary review Am J Alz Dis Other Dem 24 2009 95 121
161. M.-C. Chartier-Harlin, F. Crawford, H. Houlden, A. Warren, D. Hughes, and L. Fidani Early-onset Alzheimer's disease caused by mutations at codon 717 of
162. L. Tilley, K. Morgan, and N. Kalsheker Genetic risk factors for Alzheimer's disease J Clin Pathol Mol Pathol 51 1998 293 304 (Pubitemid 29003265)
163. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, and L. Fidani Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 349 1991 704 706 (Pubitemid 21912142)
164. S. Naruse, S. Igarashi, H. Kobayashi, K. Aoki, T. Inuzuka, and K. Kaneko Mis-sense mutation Val->Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease Lancet 337 1991 978 979
165. D. Campion, J.M. Flaman, A. Brice, D. Hannequin, B. Dubois, and C. Martin Mutations of the presenilin 1 gene in families with early-onset Alzheimer's disease Hum Mol Genet 4 1995 2373 2377
166. R. Sherrington, E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, and M. Ikeda Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Nature 375 1995 754 760
167. R.N. Kalaria Dementia comes of age in the developing world Lancet 361 2003 888 889 (Pubitemid 36332101)
168. A.D. Roses Apolipoprotein E alleles as risk factors in Alzheimer's disease Annu Rev Med 47 1996 387 400 (Pubitemid 26138899)
169. P.J. Whitehouse, D.L. Price, R.G. Struble, A.W. Clark, J.T. Coyle, and M.R. DeLong Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain Science 215 1982 1237 1239 (Pubitemid 12106486)
170. T. Gomez-Isla, J.L. Price, D.W. McKeel Jr., J.C. Morris, J.H. Growdon, and B.T. Hyman Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease J Neurosci 16 1996 4491 4500 (Pubitemid 26243044)
171. P.R. Mouton, L.J. Martin, M.E. Calhoun, G. Dal Forno, and D.L. Price Cognitive decline strongly correlates with cortical atrophy in Alzheimer's disease Neurobiol Aging 19 1998 371 377 (Pubitemid 29065485)
172. M.J. West, C.H. Kawas, L.J. Martin, and J.C. Troncoso The CA1 region of the human hippocampus is a hot spot in Alzheimer's disease Annu NY Acad Sci 908 2000 255 259 (Pubitemid 30462009)
173. D.P. Pelvig, H. Pakkenberg, L. Regeur, S. Oster, and B. Pakkenberg Neocortical glial cell numbers in Alzheimer's disease. A stereological study Dement Geriatr Cogn Disord 16 2003 212 219 (Pubitemid 37188116)
174. J.C. Troncoso, A.M. Cataldo, R.A. Nixon, J.L. Barnett, M.K. Lee, and F. Checler Neuropathology of preclinical and clinical late-onset Alzheimer's disease Ann Neurol 43 1998 673 676 (Pubitemid 28225562)
175. K.S. Kosik, C.L. Joachim, and D.J. Selkoe Microtubule-associated protein tau is a major antigenic component of paired helical filaments in Alzheimer's disease Proc Natl Acad Sci USA 83 1986 4044 4048 (Pubitemid 16062419)
176. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356 (Pubitemid 34790756)
177. C.-I. Sze, H. Bi, B.K. Kleinschmidt-DeMasters, C.M. Filley, and L.J. Martin N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease J Neurol Sci 182 2001 151 159 (Pubitemid 33786712)
178. J.A. Kemp, and R.M. McKernan NMDA receptor pathways as drug targets Nat Neurosci 5 2002 1039 1042 (Pubitemid 35247194)
179. M.P. Mattson, B. Cheng, D. Davis, K. Bryant, I. Lieberburg, and R.E. Rydel β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity J Neurosci 12 1993 376 389
180. P.H. Reddy, and M.F. Beal Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease Trends Mol Med 14 2008 45 53
181. S.T. DeKosky, and S.W. Scheff Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity Ann Neurol 27 1990 457 464 (Pubitemid 20149963)
182. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, and R. Hill Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann Neurol 30 1991 572 580
183. L.J. Martin, C.A. Pardo, L.C. Cork, and D.L. Price Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex Am J Pathol 145 1994 1358 1381 (Pubitemid 24378491)
184. C.-I. Sze, J.C. Troncoso, C. Kawas, P. Mouton, D.L. Price, and L.J. Martin Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer's disease J Neuropathol Exp Neurol 56 1997 933 994
185. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791 (Pubitemid 35231524)
186. B.A. Yankner, L.R. Dawes, S. Fisher, L. Villa-Komaroff, M.L. Oster-Granite, and R.L. Neve Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease Science 245 1989 417 420 (Pubitemid 19203368)
187. S.G. Younkin Evidence that Abeta 42 is the real culprit in Alzheimer's disease Ann Neurol 37 1995 287 288
188. T. Fath, J. Eidenmuller, and R. Brandt Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease J Neurosci 22 2002 9733 9741 (Pubitemid 35332856)
189. M. Rapoport, H.N. Dawson, L.I. Binder, M.P. Vitek, and A. Ferreira Tau is essential to β-amyloid-induced neurotoxicity Proc Natl Acad Sci USA 99 2002 6364 6369
190. H.K. Anandatheerthavarada, G. Biswas, M.A. Robin, and N.G. Avadhani Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells J Cell Biol 161 2003 41 54 (Pubitemid 36459078)
191. L. Devi, B.M. Prabhu, D.F. Galati, N.G. Avadhani, and H.K. Anandatheerthavarada Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction J Neurosci 26 2006 9057 9068 (Pubitemid 44319397)
192. M. Manczak, T.S. Anekonda, E. Henson, B.S. Park, J. Quinn, and P.H. Reddy Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression Hum Mol Genet 15 2006 1437 1449
193. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, and N. Wang ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease Science 304 2004 448 452 (Pubitemid 38495942)
194. H. Du, L. Guo, F. Fang, D. Chen, A.A. Sosunov, and G.M. McKhann Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease Nat Med 14 2008 1097 1105
195. C. Duyckaerts, M.C. Potier, and B. Delatour Alzheimer disease models and human neuropathology: similarities and differences Acta Neuropathol 115 2008 5 38 (Pubitemid 50005258)
196. S.K. Van Den Eeden, C.M. Tanner, A.L. Bernstein, R.D. Fross, A. Leimpeter, and D.A. Bloch Incidence of Parkinson's disease: variations by age, gender and race ethnicity Am J Epidemol 157 2003 1015 1022
197. J. Jankovic Parkinson's disease: clinical features and diagnosis J Neurol Neurosurg Psychiatry 79 2008 368 376 (Pubitemid 351441488)
198. J. Lowe, G. Lennox, and P.N. Leigh Disorders of movement and system degeneration D.I. Graham, P.L. Lantos, Greenfields neuropathology 1997 Arnold London 281 366
199. H. Braak, K. Del Tredici, U. Rüb, R.A.I. de Vos, E.N.H. Jansen Steur, and E. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 2003 197 211 (Pubitemid 36007810)
200. L.J. Martin Neurodegenerative disorders of the human brain and spinal cord V.S. Ramachandran, Encyclopedia of the human brain Vol. 3 2002 Elsevier Science Amsterdam 441 463
201. M. Goedert Alpha-synuclein and neurodegenerative diseases Nat Rev Neurosci 2 2001 492 501 (Pubitemid 33676584)
202. A. Ascherio, H. Chen, M.G. Weisskopf, E. O'Reilly, M.L. McCullough, and E.E. Calle Pesticide exposure and risk for Parkinson's disease Ann Neurol 60 2006 197 203 (Pubitemid 44182394)
203. A.H.V. Schapira Etiology of Parkinson's disease Neurology 66 Suppl. 4 2006 S10 S23
204. S. Shimohama, H. Swada, Y. Kitamura, and T. Taniguchi Disease model: Parkinson's disease Trends Mol Med 9 2003 360 365 (Pubitemid 37040032)
205. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, and A. Dutra Mutation in the α-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047 (Pubitemid 27443610)
206. A.B. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, and J. Kachergus Alpha-synuclein locus triplication causes Parkinson's disease Science 302 2003 841 (Pubitemid 37339619)
207. E. Leroy, R. Boyer, G. Auburger, B. Leube, G. Ulm, and E. Mezey The ubiquitin pathway in Parkinson's disease Nature 395 1998 451 452
208. V. Bonifati, P. Rizzu, M.J. van Baren, O. Schaap, G.J. Breedveld, and E. Krieger Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 299 2003 256 259 (Pubitemid 36131051)
209. Y. Hatano, Y. Li, K. Sato, S. Asakawa, Y. Yamamura, and H. Tomiyama Novel PINK1 mutations in early-onset parkinsonism Ann Neurol 56 2004 424 427 (Pubitemid 39166562)
210. T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, and S. Minoshima Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 1998 605 608 (Pubitemid 28207717)
211. E.M. Valente, P.M. Abou-Sleiman, V. Caputo, M.M. Muqit, K. Harvey, and A. Gispert Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 2004 1158 1160 (Pubitemid 38661852)
212. C. Paisán-Ruíz, S. Jain, E. Whitney Evans, W.P. Gilks, J. Simón, and M. van der Brug Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease Neuron 44 2004 595 600 (Pubitemid 39531224)
213. A. Zimprich, S. Biskup, P. Leitner, P. Lichtner, M. Farrer, and S. Lincoln Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 2004 601 607 (Pubitemid 39531225)
214. A. Ramirez, A. Heimbach, J. Grundemann, B. Stiller, D. Hampshire, and L.P. Cid Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase Nat Genet 38 2006 1184 1191 (Pubitemid 44470365)
215. C. Lesuisse, and L.J. Martin Long-term culture of mouse cortical neurons as a model for neuronal development, aging, and death J Neurobiol 51 2002 9 23 (Pubitemid 34242501)
216. L. Maroteaux, J.T. Campanelli, and R.H. Scheller Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminals J Neurosci 8 1998 2804 2815
217. D.D. Murphy, S.M. Rueter, J.Q. Trojanowski, and V.M.Y. Lee Synucleins are developmentally expressed, and α-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons J Neurosci 20 2000 3214 3220 (Pubitemid 30263139)
218. S. Chandra, F. Fornai, H.B. Kwon, U. Yazdani, D. Atasoy, and X. Liu Double knockout mice for α- and β-synucleins: effect on synaptic functions Proc Natl Acad Sci USA 101 2004 14966 14971 (Pubitemid 39410782)
219. I. Gurevicine, K. Gurevicius, and H. Tanila Role of α-synuclein in synaptic glutamate release Neurobiol Dis 28 2007 83 89 (Pubitemid 47429976)
220. S. Liu, M. Fa, I. Ninan, F. Trinchese, W. Dauer, and O. Aranico α-Synuclein involvement in hippocampal synaptic plasticity: role of NO, cGMP, cGK and CAMKII Eur J Neurosci 25 2007 3583 3596 (Pubitemid 47020438)
221. D.L. Fortin, V.M. Nemani, S.M. Voglmaier, M.D. Anthony, T.A. Ryan, and R.H. Edwards Neural activity control the synaptic accumulation of α-synuclein J Neurosci 25 2005 10913 10921 (Pubitemid 41692621)
222. S. Chandra, G. Gallardo, R. Fernandez-Chacon, O.M. Schluter, and T.C. Sudholf α-Synuclein cooperates with CSPα in preventing neurodegeneration Cell 123 2005 383 396 (Pubitemid 41546670)
223. G. Gallardo, O.M. Schluter, and T.C. Sudhof A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides Nat Neurosci 11 2008 301 308 (Pubitemid 351311805)
224. L.C. Serpell, J. Berriman, M. Jakes, M. Goedert, and R.A. Crowther Fiber diffraction of synthetic alpha synuclein filaments shows amyloid-like cross-beta conformation Proc Natl Acad Sci USA 97 2000 4897 4902 (Pubitemid 30238654)
225. K.A. Conway, S.J. Lee, J.C. Rochet, T.T. Ding, R.E. Williamson, and P.T. Lansbury Jr. Acceleration of oligomerization, not fibrilization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc Natl Acad Sci USA 97 2000 571 576 (Pubitemid 30070350)
226. B. Caughey, and P.T. Lansbury Protofibrils, pores, fibril, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders Annu Rev Neurosci 26 2003 267 298 (Pubitemid 37064935)
227. L.J. Hsu, Y. Sagara, A. Arroyo, E. Rockenstein, A. Sisk, and M. Mallory Alpha-synuclein promotes mitochondrial deficit and oxidative stress Am J Pathol 157 2000 401 410 (Pubitemid 30627559)
228. E. Junn, and M.M. Mouradian Human α-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine Neurosci Lett 320 2002 146 150 (Pubitemid 34164436)
229. S.J. Tabrizi, M. Orth, J.M. Wilkinson, J.W. Taanman, T.T. Warner, and J.M. Cooper Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity Hum Mol Genet 9 2000 2683 2689
230. B.I. Giasson, J.E. Duda, S.M. Quinn, B. Zhang, J.Q. Trojanowski, and W.M.-Y. Lee Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein Neuron 34 2002 521 533 (Pubitemid 34628750)
231. B.I. Giasson, J.E. Duda, I.V.J. Murray, Q. Chen, J.M. Souza, and H.I. Hurtig Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions Science 290 2000 985 989
232. H. Ischiropoulos Oxidative modification of alpha-synuclein Annu NY Acad Sci 991 2003 93 100
233. K.D. Wilkinson, K.M. Lee, S. Deshpande, P. Duerken-Hughes, J.M. Boss, and J. Pohl The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl terminal hydrolase Science 246 1989 670 673 (Pubitemid 19283361)
234. A. Hershko, and A. Ciechanover The ubiquitin system Annu Rev Biochem 67 1998 425 479 (Pubitemid 28411135)
235. P.T. Lansbury Jr., and A. Brice Genetics of Parkinson's disease and biochemical studies of implicated gene products Curr Opin Cell Biol 14 2002 653 660 (Pubitemid 35247750)
236. K.S. McNaught, C. Mytilineou, R. Jnobaptiste, J. Yabut, P. Shahidharan, and P. Jennert Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures J Neurochem 81 2002 301 306 (Pubitemid 34809355)
237. Y. Imai, and R. Takahashi How do Parkin mutations result in neurodegeneration? Curr Opin Neurobiol 14 2004 384 389 (Pubitemid 38759870)
238. N. Hattori, H. Matsumine, S. Asakawa, T. Kitada, H. Yoshino, and B. Elibol Point mutations (Thr240Arg and Gln311Stop) in the Parkin gene Biochem Biophys Res Commun 249 1998 754 758 (Pubitemid 28441911)
239. A. Beilina, M. Van Der Brug, R. Ahmad, S. Kesavapany, D.W. Miller, and G.A. Petsko Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability Proc Natl Acad Sci USA 102 2005 5703 5708 (Pubitemid 40559623)
240. L. Silvestri, V. Caputo, E. Bellacchio, L. Atorino, B. Dallapiccola, and E.M. Valente Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism Hum Mol Genet 14 2005 3477 3492 (Pubitemid 41672130)
241. M. Unoki, and Y. Nakamura Growth-suppressive effects of BPOZ and RGR2, two genes involved in the PTEN signaling pathway Oncogene 20 2001 4457 4465 (Pubitemid 32772428)
242. J.-M. Taymans, C. Van den Haute, and V. Baekelandt Distribution of PINK1 and LRRK2 in rat and mouse brain J Neurochem 98 2006 951 961 (Pubitemid 44051294)
243. A. Weihofen, K.J. Thomas, B.L. Ostazewski, M.R. Cooksen, and D.J. Selkoe Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking Biochemistry 48 2009 2045 2052
244. H. Deng, J. Jankovic, Y. Guo, W. Xie, and W. Le Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y Biochem Biophys Res Commun 337 2005 1133 1138 (Pubitemid 41505244)
245. R. Marongiu, B. Spencer, L. Crews, A. Adame, C. Patrick, and M. Trejo Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux J Neurochem 108 2009 1561 1574
246. M.A. Wilson, J.L. Collins, Y. Hod, D. Ringe, and G.A. Petsko The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease Proc Natl Acad Sci USA 100 2003 9256 9261 (Pubitemid 37033916)
247. H. Shang, D. Lang, B. Jean-Marc, and A. Kaelin-Lang Localization of DJ-1 mRNA in the mouse brain Neurosci Lett 367 2004 273 277 (Pubitemid 39185844)
248. R.M. Canet-Aviles, M.A. Wilson, D.W. Miller, R. Ahmad, C. McLendon, and S. Bandyopadhyay The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization Proc Natl Acad Sci USA 101 2004 9103 9108 (Pubitemid 38781618)
249. D.W. Miller, R. Ahmad, S. Hague, M.J. Baptista, R. Canet-Aviles, and C. McLendon L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system J Biol Chem 278 2003 36588 36595 (Pubitemid 37139990)
250. K. Takahashi-Niki, T. Niki, T. Taira, S.M. Iguchi-Ariga, and H. Ariga Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients Biochem Biophys Res Commun 320 2004 389 397 (Pubitemid 38798879)
251. D. Galter, M. Westerlund, A. Carmine, E. Lindqvist, O. Sydow, and L. Olson LRRK2 expression linked to dopamine-innervated areas Ann Neurol 59 2006 714 719
252. H. Melrose, S. Lincoln, G. Tyndall, D. Dickson, and M. Farrer Anatomical localization of leucine-rich repeat kinase 2 mouse brain Neuroscience 139 2006 791 794 (Pubitemid 44308089)
253. C. Iaccarino, C. Crosio, C. Vitale, G. Sanna, M.T. Carri, and P. Barone Apoptotic mechanisms in mutant LRRK2-mediated cell death Hum Mol Genet 16 2007 1319 1326 (Pubitemid 47055127)
254. C.C.-Y. Ho, H.J. Rideout, E. Ribe, C.M. Troy, and W.T. Dauer The Parkinson's disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration J Neurosci 29 2009 1011 1016
255. M.S. Goldberg, S.M. Fleming, J.J. Palacino, C. Capedam, H.A. Lam, and A. Bhatnagar Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons J Biol Chem 278 2003 43628 43635 (Pubitemid 37345989)
256. F.A. Perez, and R.D. Palmiter Parkin-deficient mice are not a robust model of parkinsonism Proc Natl Acad Sci USA 102 2005 2174 2179 (Pubitemid 40262031)
257. J.J. Palacino, D. Sagi, M.S. Goldberg, S. Krauss, C. Motz, and M. Wacker Mitochondrial dysfunction and oxidative damage in parkin-deficient mice J Biol Chem 279 2004 18614 18622 (Pubitemid 38623283)
258. L. Chen, B. Cagniard, T. Mathews, S. Jones, H.C. Koh, and Y. Ding Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice J Biol Chem 280 2005 21418 21426 (Pubitemid 40805706)
259. M.S. Goldberg, A. Pisani, M. Haburcak, T.A. Vortherms, Y. Kitada, and C. Costa Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial parkinsonism-linked gene DJ-1 Neuron 45 2005 489 496 (Pubitemid 40249861)
260. X.-H. Lu, S.M. Fleming, B. Meurers, L.C. Ackerson, F. Mortazavi, and V. Lo Bacterial artificial chromosome transgenic mice expressing a truncated mutant Parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant α-synuclein J Neurosci 29 2009 1962 1976
261. S. Gispert, D. Del Turco, L. Garrett, A. Chen, D.J. Bernard, and J. Hamm-Clement Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence or aggregate formation Mol Cell Neurosci 24 2003 419 429 (Pubitemid 37311305)
262. P.J. Kahle, M. Neumann, L. Ozmen, V. Muller, H. Jacobsen, and A. Schindzielorz Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain J Neurosci 20 2000 6365 6373
263. M.K. Lee, W. Stirling, Y. Xu, X. Xu, D. Qui, and A.S. Mandir Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice Proc Natl Acad Sci USA 99 2002 8968 8973 (Pubitemid 34693667)
264. E. Masliah, E. Rockenstein, I. Veinbergs, M. Mallory, M. Hashimoto, and A. Takeda Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders Science 287 2000 1265 1269 (Pubitemid 30112148)
265. E.K. Richfield, M.J. Thiruchelvam, D.A. Cory-Slechta, C. Wuetzer, R.R. Gainetdinov, and M.G. Caron Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice Exp Neurol 175 2002 35 48 (Pubitemid 34507908)
266. H. van der Putten, K.-H. Wiederhold, A. Probst, S. Barbieri, C. Mistl, and S. Danner Neuropathology in mice expressing human α-synuclein J Neurosci 20 2000 6021 6029 (Pubitemid 30658395)
267. M. Wakamatsu, A. Ishii, S. Iwata, J. Sakagami, Y. Ukai, and M. Ono Selective loss of nigral dopamine neurons induced by overexpression of truncated human α-synuclein Neurobiol Aging 29 2008 547 585
268. L.J. Martin, Y. Pan, A.C. Price, W. Sterling, N.G. Copeland, and N.A. Jenkins Parkinson's disease α-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death J Neurosci 26 2006 41 50 (Pubitemid 43089519)
269. A.R. Lieberman The axon reaction: a review of the principal features of perikaryal responses to axon injury Int Rev Neurobiol 14 1971 49 124
270. H.F. Poon, M. Frasier, N. Shreve, V. Calabrese, B. Wolozin, and D.A. Butterfield Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice - a model of familial Parkinson's disease Neurobiol Dis 18 2005 492 498 (Pubitemid 40332708)
271. S. Turnbull, B.J. Tabner, O.M. El-Agnaf, S. Moore, Y. Davies, and D. Allsop Alpha-synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro Free Radic Biol Med 30 2001 1163 1170 (Pubitemid 32441842)
272. E. Paxinou, Q. Chen, M. Weisse, B.I. Giasson, E.H. Norris, and S.M. Rueter Induction of alpha-synuclein aggregation by intracellular nitrative insult J Neurosci 21 2001 8053 8061 (Pubitemid 32952762)
273. J.M. Souza, B.I. Giasson, Q. Chen, V.M.-Y. Lee, and H. Ischiropoulos Dityrosine cross-linking promotes formation of stable α-synuclein polymers J Biol Chem 265 2000 18344 18349
274. L.J. Martin, Z. Liu, K. Chen, A.C. Price, Y. Pan, and J.A. Swaby Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death J Comp Neurol 500 2007 20 46 (Pubitemid 44904300)
275. K. Chen, F.J. Northington, and L.J. Martin Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice Brain Struct Funct 214 2010 219 234
276. L.P. Rowland, and N.A. Shneider Amyotrophic lateral sclerosis N Engl J Med 344 2001 1688 1700 (Pubitemid 32479968)
277. S. Sathasivam, P.G. Ince, and P.J. Shaw Apoptosis in amyotrophic lateral sclerosis: a review of the evidence Neuropathol Appl Neurobiol 27 2001 257 274 (Pubitemid 32758614)
278. B. Stephens, R.J. Guiloff, R. Navarrete, P. Newman, N. Nikhar, and P. Lewis Widespread loss of neuronal populations in spinal ventral horn in sporadic motor neuron disease. A morphometric study J Neurol Sci 244 2006 41 58
279. S. Maekawa, S. Al-Sarraj, M. Kibble, S. Landau, J. Parnavelas, and D. Cotter Cortical selective vulnerability in motor neurons disease: a morphometric study Brain 127 2004 1237 1251 (Pubitemid 38745505)
280. S. Zoccolella, A. Santamato, and P. Lamberti Current and emerging treatments for amyotrophic lateral sclerosis Neuropsychiatr Dis Treat 5 2009 577 595
281. E. Kabashi, P.N. Valdmains, P. Dion, D. Spiegelman, B.J. McConkey, and C. Vande Velde TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis Nat Genet 40 2008 572 574 (Pubitemid 351601218)
282. H.-X. Deng, A. Hentati, J.A. Tainer, Z. Iqbal, A. Cayabyab, and W.-Y. Hung Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase Science 261 1993 1047 1051 (Pubitemid 23300865)
283. C. Vance, B. Rogelj, T. Hortobagyi, K.J. de Vos, A.L. Nishimura, and J. Sreedharan Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 Science 323 2009 1208 1211
284. J.C. Schymick, K. Talbot, and G.J. Traynor Genetics of amyotrophic lateral sclerosis Hum Mol Genet 16 2007 R233 R242
285. C.Y. Chow, J.E. Lander, S.K. Bergren, P.C. Sapp, A.E. Grant, and J.M. Jones Deleterious variants of FIG4, a phosphoinositade phosphatase, in patients with ALS Am J Hum Genet 84 2009 85 88
286. S. Sasaki, and M. Iwata Ultrastructural changes of synapses of Betz cell in patients with amyotrophic lateral sclerosis Neurosci Lett 268 1999 29 32 (Pubitemid 29292537)
287. F.M. Menzies, P.G. Ince, and P.J. Shaw Mitochondrial involvement in amyotrophic lateral sclerosis Neurochem Int 40 2002 543 551 (Pubitemid 34159155)
288. G.P. Comi, A. Bordoni, S. Salani, L. Franeschina, M. Sciacco, and A. Prelle Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease Ann Neurol 43 1998 110 116 (Pubitemid 28124656)
289. G.M. Borthwick, R.W. Taylo, T.J. Walls, K. Tonska, G.A. Taylor, and P.J. Shaw Motor neuron disease in a patient with a mitochondrial tRNAIle mutation Ann Neurol 59 2006 570 574 (Pubitemid 43358082)
290. C. Mawrin, E. Kirches, G. Krause, F.R. Wiedemann, C.K. Vorwerk, and B. Bogerts Single-cell analysis of mtDNA levels in sporadic amyotrophic lateral sclerosis Neuroreport 15 2004 939 943 (Pubitemid 38591239)
291. A. Bender, K.J. Krishnan, C.M. Morris, G.A. Taylor, A.K. Reve, and R.P. Perry High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson's disease Nat Genet 38 2006 515 517
292. Y. Kraytsberg, E. Kudryavtseva, A.C. McKee, C. Geula, N.W. Kowall, and K. Khrapko Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons Nat Genet 38 2006 518 520
293. 2 + signaling Curr Opin Neurobiol 8 1998 398 404 (Pubitemid 28288577)
294. L. Siklos, J. Engelhardt, Y. Harat, R.G. Smith, F. Joo, and S.H. Appel Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis Ann Neurol 39 1996 203 216 (Pubitemid 26071571)
295. J.D. Rothstein, L.J. Martin, and R.W. Kuncl Decreased glutamate transport by brain and spinal cord in amyotrophic lateral sclerosis N Engl J Med 326 1992 1464 1468
296. J.D. Rothstein, M. Van Kammen, A.I. Levey, L.J. Martin, and R.W. Kuncl Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis Ann Neurol 38 1995 73 84
297. P.R. Heath, J. Tomkins, P.G. Ince, and P.J. Shaw Quantitative assessment of AMPA receptor mRNA in human spinal motor neurons isolated by laser capture microdissection Neuroreport 13 2002 1753 1757 (Pubitemid 35333155)
298. S. Kwak, and Y. Kawahara Deficient RNA editing of GluR2 and neuronal death in amyotrophic lateral sclerosis J Mol Med 83 2005 110 120 (Pubitemid 40379299)
299. D.T.W. Chang, and I.J. Reynolds Mitochondrial trafficking and morphology in healthy and injured neurons Prog Brain Res 80 2006 241 268 (Pubitemid 46028946)
300. M.J. Hansson, R. Mansson, S. Morota, H. Uchino, T. Kallur, and T. Sumi Calcium-induced generation of reactive oxygen species in brain mitochondria is mediated by permeability transition Free Radic Biol Med 45 2008 284 294
301. 2 + levels in brainstem motoneurones J Physiol 555 2004 45 59 (Pubitemid 38324500)
302. M.F. Beal Oxidatively modified protein in aging and disease Free Radic Biol Med 32 2002 797 803 (Pubitemid 34439250)
303. R.J. Ferrante, S.E. Browne, L.A. Shinobu, A.C. Bowling, M.J. Baik, and U. MacGarvey Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis J Neurochem 69 1997 2064 2074 (Pubitemid 27452754)
304. K. Abe, L.-H. Pan, M. Watanabe, T. Kato, and Y. Itoyama Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis Neurosci Lett 199 1995 152 154
305. M.F. Beal, R.J. Ferrante, S.E. Browne, R.T. Matthews, N.W. Kowall, and R.H. Brown Jr. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis Ann Neurol 42 1997 644 654 (Pubitemid 27439028)
306. S. Sasaki, H. Warita, K. Abe, and M. Iwata Inducible nitric oxide synthase (iNOS) and nitrotyrosine immunoreactivity in the spinal cords of transgenic mice with mutant SOD1 gene J Neuropathol Exp Neurol 60 2001 839 846 (Pubitemid 32880591)
307. S.E. Browne, A.C. Bowling, M.J. Baik, M. Gurney, R.H. Brown Jr., and M.F. Beal Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis J Neurochem 71 1998 281 287 (Pubitemid 28292560)
308. G.M. Borthwick, M.A. Johnson, P.G. Ince, P.J. Shaw, and D.M. Turnbull Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death Ann Neurol 46 1999 787 790 (Pubitemid 29518143)
309. S. Vielhaber, D. Kunz, K. Winkler, F.R. Wiedemann, E. Kirches, and H. Feistner Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis Brain 123 2000 1339 1348 (Pubitemid 30420935)
310. G. Soraru, L. Vergani, L. Fedrizzi, C. D'Ascenzo, A. Polo, and B. Bernazzi Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients Neuropathol Appl Neurobiol 33 2007 204 211 (Pubitemid 46385714)
311. A. Echaniz-Laguna, J. Zoll, E. Ponsot, B. N'Guessan, C. Tranchant, and J.-P. Loeffler Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man Exp Neurol 198 2006 25 30 (Pubitemid 43243741)
312. L.J. Martin Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism J Neuropathol Exp Neurol 58 1999 459 471 (Pubitemid 29220739)
313. L.J. Martin, and Z. Liu Opportunities for neuroprotection in ALS using cell death mechanism rationales Drug Discov Today 1 2004 135 143 (Pubitemid 41123763)
314. S.D. Ginsberg, S.E. Hemby, E.J. Mufson, and L.J. Martin Cell and tissue microdissection in combination with genomic and proteomic profiling L. Zaborszky, F.G. Wouterlood, J.L. Lanciego, Neuroanatomical tract-tracing 3, molecules, neurons, and systems 2006 Springer New York 109 141
315. L.J. Martin p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis Neurobiol Dis 7 2000 613 622 (Pubitemid 32044286)
316. L.J. Martin The apoptosis-necrosis cell death continuum in CNS development, injury and disease: contributions and mechanisms E.H. Lo, J. Marwah, Neuroprotection 2002 Prominent Press Scottsdale, AZ 379 412
317. L.J. Martin, A.C. Price, A. Kaiser, A.Y. Shaikh, and Z. Liu Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death Int J Mol Med 5 2000 3 13
318. Z. Liu, and L.J. Martin Motor neurons rapidly accumulate DNA single-strand breaks after in vitro exposure to nitric oxide and peroxynitrite and in vivo axotomy J Comp Neurol 432 2001 35 60 (Pubitemid 32187019)
319. M. Wong, and L.J. Martin Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice Hum Mol Genet 9 2010 2284 2302
320. B.J. Turner, and K. Talbot Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS Prog Neurobiol 85 2008 94 134
321. J.M. McCord, and I. Fridovich Superoxide dismutase, an enzymic function for erythrocuprein (hemocuprein) J Biol Chem 244 1969 6049 6055
322. R. Rakhit, J.P. Crow, J.R. Lepock, L.H. Kondejewski, N.R. Cashman, and A. Chakrabartty Monomeric Cu, Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic sclerosis J Biol Chem 279 2004 15499 15504 (Pubitemid 38618950)
323. A. Ferri, M. Cozzolino, C. Crosio, M. Nencini, A. Casciati, and E.B. Gralla Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials Proc Natl Acad Sci USA 103 2006 13860 13865 (Pubitemid 44413998)
324. A.G. Estévez, J.P. Crow, J.B. Sampson, C. Reiter, Y. Zhuang, and G.J. Richardson Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase Science 286 1999 2498 2500
325. S.W. Flanagan, R.D. Anderson, M.A. Ross, and L.W. Oberley Overexpression of manganese superoxide dismutase attenuates neuronal death in human cells expressing mutant (G37R) Cu/Zn-superoxide dismutase J Neurochem 81 2002 170 177 (Pubitemid 34808864)
326. L.G. Bilsland, N. Nirmalananthan, J. Yip, L. Greensmith, and M.R. Duhcen Expression of mutant SOD1G93A in astrocytes induces functional deficits in motoneuron mitochondria J Neurochem 107 2008 1271 1283
327. M.E. Gurney, H. Pu, A.Y. Chiu, M.C. Dal Canto, C.Y. Polchow, and D.D. Alexander Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation Science 264 1994 1772 1775 (Pubitemid 24227760)
328. M.C. Dal Canto, and M.E. Gurney Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis Am J Pathol 145 1994 1271 1279 (Pubitemid 24378480)
329. Q. Chang, and L.J. Martin Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice: a confocal quantitative analysis Am J Pathol 174 2009 574 585
330. C. Bendotti, N. Calvaresi, L. Chiveri, A. Prelle, M. Moggio, and M. Braga Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity J Neurol Sci 191 2001 25 33 (Pubitemid 33035892)
331. P.C. Wong, C.A. Pardo, D.R. Borchelt, M.K. Lee, N.G. Copeland, and N.A. Jenkins An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria Neuron 14 1995 1105 1116
332. J. Kong, and Z. Xu Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1 J Neurosci 18 1998 3241 3250 (Pubitemid 28186017)
333. D. Jaarsma, F. Rognoni, W. van Duijn, H.W. Verspaget, E.D. Haasdijk, and J.C. Holstege CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations Acta Neuropathol 102 2001 293 305 (Pubitemid 32894698)
334. S. Sasaki, H. Warita, T. Murakami, K. Abe, and M. Iwata Ultrastructural study of mitochondria in the spinal cord of transgenic mice with a G93A mutant SOD1 gene Acta Neuropathol 107 2004 461 474 (Pubitemid 38559256)
335. D.R. Borchelt, M.K. Lee, H.H. Slunt, M. Guarnieri, Z.-S. Xu, and P.C. Wong Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity Proc Natl Acad Sci USA 91 1994 8292 8296 (Pubitemid 24253933)
336. M.B. Yim, J.-H. Kang, H.-S. Yim, H.-S. Kwak, P.B. Chock, and E.R. Stadtman A gain-of-function of an amyotrophic lateral sclerosis-associated Cu, Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide Proc Natl Acad Sci USA 93 1996 5709 5714 (Pubitemid 26190744)
337. E. Kabashi, P.N. Valdmanis, P. Dion, and G.A. Rouleau Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis? Ann Neurol 62 2007 553 559
338. S.A. Ezzi, M. Urushitani, and J.-P. Julien Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation J Neurochem 102 2007 170 178 (Pubitemid 46906269)
339. S.I. Liochev, and I. Fridovich Mutant Cu, Zn superoxide dismutases and familial amyotrophic lateral sclerosis: evaluation of oxidative hypotheses Free Radic Biol Med 34 2003 1383 1389 (Pubitemid 36570411)
340. P. Pacher, J.S. Beckman, and L. Liaudet Nitric oxide and peroxynitrite in health and disease Physiol Rev 87 2007 315 424 (Pubitemid 46217686)
341. P.K. Andrus, T.J. Fleck, M.E. Gurney, and E.D. Hall Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis J Neurochem 71 1998 2041 2048 (Pubitemid 28491560)
342. H.F. Poon, K. Hensley, V. Thongboonkerd, M.L. Merchant, B.C. Lynn, and W.M. Pierce Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice - a model of familial amyotrophic lateral sclerosis Free Radic Biol Med 39 2005 435 462
343. A. Okado-Matsumoto, and I. Fridovich Subcellular distribution of superoxide (SOD) in rat liver J Biol Chem 276 2001 38388 38393
344. C.M.J. Higgins, C. Jung, H. Ding, and Z. Xu Mutant Cu Zn Superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS J Neurosci 22 RC215 2002 1 6
345. P. Pasinelli, M.E. Belford, N. Lennon, B.J. Bacskai, B.T. Hyman, and D. Trotti Amyotrophic lateral sclerosis-associated SOD1 mutant protein bind and aggregate with Bcl-2 in spinal cord mitochondria Neuron 43 2004 19 30 (Pubitemid 38952816)
346. G. Goldsteins, V. Keksa-Goldsteine, T. Ahtiniemi, M. Jaronen, E. Arens, and K. Akerman Deleterious role of superoxide dismutase in the mitochondrial intermembrane space J Biol Chem 283 2008 8446 8452
347. C.M. Higgins, C. Jung, and Z. Xu ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes BMC Neurosci 4 2003 16
348. K.J. De Vos, A.L. Chapman, M.E. Tennant, C. Manser, E.L. Tudor, and K.-F. Lau Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondrial content Hum Mol Genet 16 2007 2720 2728 (Pubitemid 350018514)
349. L.J. Martin, K. Chen, and Z. Liu Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation J Neurosci 25 2005 6449 6459 (Pubitemid 40962540)
350. L. Siklos, J.I. Engelhardt, M.E. Alexianu, M.E. Gurney, T. Siddique, and S.H. Appel Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice J Neuropathol Exp Neurol 57 1998 571 587 (Pubitemid 28265600)
351. G93A mice Mol Pharmacol 75 2009 478 489
352. 2 + uptake is greater in mutant SOD1 than in wild-type mouse motor terminals Proc Natl Acad Sci USA 106 2009 2007 2011
353. S. Sasaki, N. Shibata, T. Komori, and M. Iwata iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis Neurosci Lett 291 2000 44 48 (Pubitemid 30658109)
354. L.J. Martin Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis IDrugs 13 2010 568 580
355. W.S. Kunz Different metabolic properties of mitochondrial oxidative phosphorylation in different cell types - important implications for mitochondrial cytopathies Exp Physiol 88 1 2003 149 154 (Pubitemid 36150068)
356. M. Keep, E. Elmér, K.S.K. Fong, and K. Csiszar Intrathecal cyclosporin prolongs survival of late-stage ALS mice Brain Res 894 2001 27 331
357. J. Karlsson, K.S. Fong, M.J. Hansson, E. Elmer, K. Csiszar, and M.F. Keep Life span extension and reduced neuronal death after weekly intraventricular cyclosporine injections in the G93A transgenic mouse model of amyotrophic lateral sclerosis J Neurosurg 101 2004 128 137 (Pubitemid 38808472)
358. I.G. Kirkinezos, D. Hernandez, W.G. Bradley, and C.T. Moraes An ALS mouse model with a permeable blood-brain barrier benefits from systemic cyclosporine A treatment J Neurochem 88 2004 821 826 (Pubitemid 38199302)
359. T. Bordet, B. Buisson, M. Michaud, C. Drouot, P. Galea, and P. Delaage Identification and characterization of Cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis J Pharmacol Exp Ther 322 2007 709 720 (Pubitemid 47105813)
360. C. Mills, M. Makwana, A. Wallace, S. Benn, H. Schmidt, and I. Tegeder Ro5-4864 promotes neonatal motor neuron survival and nerve regeneration in adult rats Eur J Neurosci 27 2008 937 946 (Pubitemid 351365176)
361. L.-J. Yan, and R.S. Sohal Mitochondrial adenine nucleotide translocase is modified oxidatively during aging Proc Natl Acad Sci USA 95 1998 12896 12901 (Pubitemid 28509494)
362. L. Prokai, L.-J. Yan, J.L. Vera-Serrano, S.M. Stevens Jr., and M.J. Forster Mass spectrometry-based survey of age-associated protein carbonylation in rat brain mitochondria J Mass Spectrom 42 2007 1583 1589
363. H.L.A. Vieira, A.-S. Belzacq, D. Haouzu, F. Bernassola, I. Cohen, and E. Jacotot The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal Oncogene 20 2001 4305 4316 (Pubitemid 32726872)
364. G.P. McStay, S.J. Clarke, and A.P. Halestrap Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore Biochem J 367 2002 541 548 (Pubitemid 35216831)
365. K.A. Trumbull, and J.S. Beckman A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis Antioxid Redox Signal 11 2009 1627 1639
366. P. Costantini, A.-S. Belzacq, H.L.A. Vieira, N. Larochette, M.A. de Pablo, and N. Zamzami Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis Oncogene 19 2000 307 314 (Pubitemid 30077228)
367. N. García, E. Martínez-Abundis, N. Pavón, F. Correa, and E. Chávez Copper induces permeability transition through its interaction with the adenine nucleotide translocase Cell Biol Int 31 2007 893 899 (Pubitemid 46830899)
368. S. Grimm, and D. Brdiczka The permeability transition pore in cell death Apoptosis 12 2007 841 855 (Pubitemid 46653295)
369. M. Forte, B.G. Gold, G. Marracci, P. Chaudhary, E. Basso, and D. Johnsen Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis Proc Natl Acad Sci USA 104 2007 7558 7563 (Pubitemid 47185945)
370. A.C. Schinzel, O. Takeuchi, Z. Huang, J.K. Fisher, Z. Zhou, and J. Rubens Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia Proc Natl Acad Sci USA 102 2005 12005 12010 (Pubitemid 41291119)
371. P.H. Gordon, D.H. Moore, R.G. Miller, J.M. Florence, J.L. Verheijde, and C. Doorish Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomized trial Lancet Neurol 6 2007 1045 1053 (Pubitemid 350116691)
372. J. Simon-Sanchez, and A.B. Singleton Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls Hum Mol Genet 17 2008 1988 1993 (Pubitemid 351865847)
373. J. Burré, M. Sharma, T. Tsetsenis, V. Buchman, M. Etherton, and T.C. Sudhof α-Synulcein promotes SNARE-complex assembly in vivo and in vitro Science 329 5999 2010 1663 1667
374. P. Garcia-Reitbock, O. Anichtchik, A. Bellucci, M. Iovino, C. Ballini, E. Fineberg, and B. Ghetti SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease Brain 133 2010 2032 2044